Cooper to study spine development

John A. Cooper, MD, PhD, a professor in biochemistry and molecular biophysics at the School of Medicine, received a one-year $613,251 grant from National Institute of Mental Health, part of the National Institutes of Health (NIH).

Glitches in the matrix

Glitches in the matrix
As reported in a paper in Nature Communications, physicist Chong Zu in Arts & Sciences and his team are finding new ways to harness the quantum power of defects in otherwise flawless crystals. 

Diagnosis of rare, genetic muscle disease improved by new approach

Researchers at the School of Medicine have developed an approach that could help doctors distinguish between the many subtypes of limb girdle muscular dystrophy, a rare, genetic muscle disease. With new therapies poised to enter the clinic, identifying the precise subtype is necessary to ensure access to the most appropriate treatment.

Dybvig presents at international conference

Philip H. Dybvig, a banking and finance expert at Olin Business School, was a key speaker at the 2023 Asian Leadership Conference, Korea’s premier international conference, in May.

Altered gut bacteria may be early sign of Alzheimer’s disease

A study by researchers at Washington University School of Medicine reveals that the bacteria that live in the gut change long before Alzheimer’s disease symptoms arise. The discovery could lead to diagnostics or treatments for Alzheimer’s disease that target the gut microbiome.

Carter to depart for role in North Carolina

Dedric Carter
Dedric Carter is stepping down from his role as vice chancellor for innovation and chief commercialization officer at Washington University in St. Louis to take a position at the University of North Carolina at Chapel Hill, according to Chancellor Andrew D. Martin. His appointment is effective Oct. 30.